Mississauga, ON -- (SBWIRE) -- 03/08/2016 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Bio-Path Announces Research Collaboration with Leading Oncology Institution."
Companies mentioned in this article include Merck & Company (NYSE:MRK), Pfizer Inc. (NYSE:PFE) and Bio-Path Holdings Inc. (NASDAQ:BPTH).
Spending on oncology drugs crossed $100 billion in 2014 and the trend is expected to continue. The availability of new treatment options and treatment costs have been the key drivers of growth in oncology spending.
Increasing spending on cancer drugs has not surprisingly piqued the interests of major pharmaceutical and biotechnology companies. The likes of Merck & Company (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) have been spending billions of dollars in research on new oncology products. However, the research is not restricted to large cap companies. Several small cap companies in the biotech space are focusing on oncology. One such company is Bio-Path Holdings Inc. (NASDAQ:BPTH).
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.